MSN Laboratories Private Limited Erlotinib Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Erlotinib Export Records India — #2 Exporter, 32 Shipments, $529.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Erlotinib

India Pharmaceutical Trade Intelligence

$2.7M94 Suppliers55 CountriesHS 30049049

ExportsIndia → UNITED STATES21.0%India → THAILAND18.9%

ImportsITALY → India$377.7K BRAZIL → India$19.7K

#1 Supplier: NATCO PHARMA #1 Buyer: ATLANTA MEDICARE

MSN Laboratories Private Limited — Erlotinib Exporter #2 | $529.7K Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Erlotinib Exporter Profile

Indian Pharmaceutical Exporter · #2 for Erlotinib · $529.7K export value · DGFT Verified

MSN Laboratories Private Limited is the #2 Indian exporter of Erlotinib with $529.7K in export value and 32 verified shipments. MSN Laboratories Private Limited holds a 19.8% market share in Erlotinib exports across 6 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Erlotinib Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Erlotinib export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Erlotinib?

Country	Value	Shipments	Share
UNITED STATES	$166.3K	8	39.2%
PERU	$118.0K	6	27.8%
CHILE	$81.8K	8	19.3%
AUSTRALIA	$37.0K	4	8.7%

Who Are the Top Buyers of Erlotinib from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	AUSTRALIA	$160.9K	9
MSN LABS PERU SAC CAL.	PERU	$53.3K	3
'TO THE ORDER	CHILE	$43.3K	2
MSN LABS CHILE SPA RUT	CHILE	$38.5K	1
MSN LABS PERU SAC	PERU	$37.2K	2
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$35.7K	2
TO THE ORDER MSN LABS PERU SAC CAL	PERU	$27.6K	1
TO THE ORDER	UNITED STATES	$17.4K	1
APOTEX PTY LIMITED	AUSTRALIA	$8.3K	2
APOTEX PTY LTD	AUSTRALIA	$2.3K	1

MSN Laboratories Private Limited supplies Erlotinib to 13 buyers globally. The largest buyer is TO THE ORDER OF (AUSTRALIA), followed by MSN LABS PERU SAC CAL. (PERU) and 'TO THE ORDER (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Erlotinib Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
ERLOTINIB TAB 150MG 30 S NOVADOZ	$69.6K	2
ERLOTINIB TAB 150MG 30'S NOVADOZ	$44.0K	2
MSN PHARMACEUTICALS: ERLOTINIB 100MG (3X	$40.0K	1
MSN PHARMACEUTICAL PRODUCT NAME: ERLOTINIB 150MG 3x10's0 MSN -CL ALONG WITH 195NOS FREE SAMPLE	$38.5K	1
LOTYRO 150MG (3X10'S)-ERLOTINIB 150 MG MSN -PENOS	$27.8K	1
LOTYRO 150MG 3X10'S-ERLOTINIB 150MG MSN-PE	$27.6K	1
LOTYRO 150MG (3X10S)-ERLOTINIB 150 MG MSN-PENOS	$26.6K	1
MSN PHARMACEUTICALS - ERLOTINIB APOTEX 1	$26.3K	1
ERLOTINIB TABLET 100 MG	$23.9K	1
LOTYRO 150MG (3X10'S)-ERLOTINIB 150 MG MSN-PENOS	$22.6K	1

MSN Laboratories Private Limited exports 30 distinct Erlotinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERLOTINIB TAB 150MG 30 S NOVADOZ with 2 shipments worth $69.6K.

How Does MSN Laboratories Private Limited Compare to Nearest Erlotinib Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	NATCO PHARMA LIMITED	$547.2K	11	3	$49.7K
2	MSN LABORATORIES PRIVATE LIMITED ★	$529.7K	32	6	$16.6K
4	VEXXA LIFESCIENCES PVT. LTD.	$253.4K	16	1	$15.8K
3	CIPLA LIMITED	$200.0K	4	2	$50.0K

MSN Laboratories Private Limited ranks #2 among 94 Indian Erlotinib exporters. Average shipment value of $16.6K compared to the market average of $21.1K. The closest competitors by value are NATCO PHARMA LIMITED and VEXXA LIFESCIENCES PVT. LTD..

Which Indian Ports Ship Erlotinib Exports?

Port	Shipments	% Share
SAHAR AIR	71	21.1%
SAHAR AIR CARGO ACC (INBOM4)	65	19.3%
DELHI AIR CARGO ACC (INDEL4)	34	10.1%
DELHI AIR	27	8.0%
HYDERABAD AIR	24	7.1%
Bombay Air	21	6.3%
HYDERABAD ACC (INHYD4)	18	5.4%
Bombay Air Cargo	7	2.1%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Erlotinib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Erlotinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 32 individual customs records matching MSN Laboratories Private Limited exporting Erlotinib, covering 30 formulations to 7 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 55+ countries, 144+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Erlotinib

Erlotinib

MSN Laboratories Private Limited — Erlotinib Exporter Profile

MSN Laboratories Private Limited — Erlotinib Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Erlotinib?

Who Are the Top Buyers of Erlotinib from MSN Laboratories Private Limited?

What Is India's Total Erlotinib Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Erlotinib Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Erlotinib Exporters?

What Erlotinib Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Erlotinib to Key Markets

United States — FDA

How Does MSN Laboratories Private Limited Compare to Nearest Erlotinib Exporters?

Which Indian Ports Ship Erlotinib Exports?

What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Erlotinib Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Erlotinib Export Data from MSN Laboratories Private Limited

Erlotinib Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source